Anti-atherogenic effects of the acyl-CoA:cholesterol acyltransferase inhibitor, avasimibe (CI-1011), in cultured primary human macrophages

Atherosclerosis

Volumn 161, Issue 1, 2002, Pages 45-54

  Rodriguez, Annabelle ^a,b   Usher, David C ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF DELAWARE   (United States)

Author keywords

ACAT; Apolipoprotein E; Foam cells; Macrophages

Indexed keywords

ADENINE; APOLIPOPROTEIN E; AVASIMIBE; CHOLESTEROL ACYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; SCAVENGER RECEPTOR;

ARTICLE; CELL MATURATION; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; FEMALE; FOAM CELL; HUMAN; HUMAN CELL; ISOTOPE LABELING; LIPID STORAGE; LIPOPROTEIN SECRETION; MACROPHAGE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN TRANSPORT;

ACETATES; APOLIPOPROTEINS E; CELLS, CULTURED; CHOLESTEROL; HUMANS; LIPOPROTEINS, LDL; MACROPHAGES; STEROL O-ACYLTRANSFERASE; SULFONIC ACIDS;

EID: 0036188692     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(01)00620-7     Document Type: Article

References (24)

1. The cholesteryl ester cycle in macrophage foam cells
2. Novel effects of the acyl-Coenzyme A:cholesterol acyltransferase inhibitor 58-035 on foam cell development in primary human monocyte-derived macrophages
3. Disruption of the acyl-CoA:cholesterol acyltransferase gene in mice: Evidence suggesting multiple cholesterol esterification enzymes in mammals
4. Inhibitors of acyl-CoA:cholesterol O-acyl transferase (ACAT) as hypocholesterolemic agents
5. Stimulation of cholesterol release from rabbit foam cells by the action of a new inhibitor for acyl CoA:cholesterol acyltransferase (ACAT), HL-004
6. Effect of the acyl-CoA:cholesterol acyltransferase inhibitor, E5324, on experimental atherosclerosis in rabbits
7. Avasimibe, treatment of lipoprotein disorders
8. The acyl-CoA:cholesterol acyltransferase (ACAT)-inhibitor avasimibe reduces atherosclerosis independently of its lipid-lowering effect in cholesterol-fed apoE3-Leiden transgenic mice
9. The ACAT inhibitor avasimibe reduces macrophages and matrix metalloproteinase expression in atherosclerotic lesions of hypercholesterolemic rabbits
10. The effects of atorvastatin, the ACAT inhibitor CI-1011, and progesterone on storage and secretion of cholesterol in human monocyte-derived macrophages
11. Distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum
12. Methods for investigating the essential groups for enzyme activity
13. Enhanced macrophage uptake of low density lipoprotein after self-aggregation
14. Quantitative analysis of cholesterol in 5 to 20 microliters of plasma
15. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples
16. Short-term measurement of catabolic rates using iodine-labeled plasma proteins
17. High affinity uptake and degradation of apolipoprotein E-free high density lipoprotein in cultured porcine hepatocytes
18. Cell toxicity induced by inhibition of acyl Coenzyme A:cholesterol acyltransferase and accumulation of unesterified cholesterol
19. Apolipoprotein E produced by human monocyte-derived macrophages mediates cholesterol efflux that occurs in the absence of added cholesterol acceptors
20. Effects of intracellular free cholesterol accumulation on macrophage viability, a model for foam cell death
21. Production of cholesterol-enriched nascent high density lipoproteins by human monocyte-derived macrophages is a mechanism that contributes to macrophage cholesterol efflux
22. Aggregated low density lipoprotein induces and enters surface-connected compartments of human monocyte macrophages
23. The secretion of apolipoprotein E by human monocyte-derived macrophages
24. Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl-CoA:cholesterol acyltransferase I